This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Allscripts And Inovalon Enter Into Strategic Agreement

BOWIE, Md., Sept. 12, 2013 /PRNewswire/ -- Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced that Allscripts (NASDAQ: MDRX) and Inovalon have entered into a multi-year agreement that enables Inovalon's advanced healthcare data analytics for payers to leverage Allscripts Electronic Health Record (EHR) Platform to improve clinical and quality outcomes and financial performance.


Advanced healthcare technologies are needed for the payer, provider, and patient to succeed together. With this agreement, Inovalon will apply its advanced quality improvement and risk score accuracy analytics to Allscripts EHR Platform, improving the speed and workflow efficiency of data exchanges within the medical record process between payers and providers.

"Payers and providers increasingly enter into shared risk relationships to improve clinical and quality outcomes as well as financial performance within the broader healthcare environment," said Keith Dunleavy, M.D., President and Chief Executive Officer of Inovalon. "We are pleased to be working with Allscripts to bring these technological advancements to payers and clinicians across the country."

The combination of thousands of disease, diagnosis, treatment, and care considerations together with the expanding complexity of regulatory oversight, quality measurement requirements, reimbursement models, and healthcare organization structures has resulted in a significant increase in burden within the healthcare landscape. Today, payers and providers alike must maintain extensive resources and subject matter expertise in an effort to comply, let alone excel, in the current environment. Additionally, in order to substantiate performance and regulatory adherence with such programs as NCQA HEDIS ® quality performance measurement, the CMS Five-Star Quality Rating program, and other federal and state-based risk score accuracy programs, providers and payers must support extensive medical record review initiatives. Through the integration of analytics and electronic medical record data abstraction, the integration of Inovalon's toolsets within the Allscripts environment decreases the burden for both the payer and the provider while increasing quality outcomes and risk score data accuracy.

"With the expansion of complex managed-care program environments, data-driven platforms have become increasingly crucial for all segments of the healthcare continuum," said Faisal Mushtaq, General Manager, Payer & Life Sciences for Allscripts. "Our collaboration with Inovalon provides payers with valuable insights and improvement capabilities so that they, in turn, can more effectively partner with providers to drive more efficient and effective care."

About Allscripts

Allscripts (NASDAQ: MDRX) delivers the insights that healthcare providers require to generate world-class outcomes. The company's Electronic Health Record, practice management and other clinical, revenue cycle, connectivity and information solutions create a Connected Community of Health™ for physicians, hospitals and post-acute organizations.  To learn more about Allscripts, please visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

About Inovalon, Inc.

Inovalon, Inc. is a leading technology-enabled healthcare solutions provider focused on the importance of healthcare data and its ability to drive dramatic, objective improvement in clinical and quality outcomes, care management and financial performance throughout the healthcare community. Proprietary healthcare datasets, aggregation and analysis capabilities, combined with a national infrastructure of leading-edge technology, clinical prowess and deep human resources, empower Inovalon's advanced generation of healthcare assessment and improvement through highly informed solutions. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance ­-- while also bringing to bear the resources to resolve them. This differentiating combination provides a powerful capability suite, touching more than 540,000 physicians, 220,000 clinical facilities, and more than 120 million Americans, driving high‐value impact, improving the quality and economics for health plans, hospitals, physicians, patients, and researchers. Please visit for more information.

SOURCE Inovalon, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%
YHOO $27.97 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs